About this trial
Macrosomia is associated with increased risks for both the mother and the baby, including complications during delivery, injuries, and even death. The accurate diagnosis of macrosomia is often difficult before birth. There are a number of factors that can increase the risk of macrosomia, such as maternal obesity, diabetes, and excessive weight gain during pregnancy. There are also a number of different techniques that can be used to try to predict macrosomia, but none of them are perfect.
The aim of this study is to evaluate sensitivity of measuring fetal clavicle length in third trimester compared with biacromial diameter and Hadlock formula IV for prediction of fetal macrosomia.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Singleton pregnancy.
Gestational age between 37-42 weeks.
Accepting to be included in the study.
Disqualifiers
Congenital fetal malformation affecting birth weight or affecting clavicle.
Trial population
pregnant women with gestational age between 37 weeks and 42 weeks
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Obstetric Ultrasound
DeviceMeasuring fetal clavicular length and estimated fetal weight using Hadlock IV formula and Youssef's formula.
Treatment groups
Trial outcomes
Primary outcomes
Third trimester clavicle length measurement
Sensitivity of third trimester clavicle length measurement in comparison with biacromial diameter and Hadlock IV formula in predicting fetal macrosomia
Secondary outcomes
Establish the relationship between third-trimester clavicle length and shoulder dystocia
establishing if clavicle length is predictive of shoulder dystocia or not.
Mode of delivery
either vaginal delivery or Cesarean section
Gestational age at the time of delivery.
gestational age and its relation to birth weight
Neonatal Apgar score.
neonatal health evaluation
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: